STAT3 and lung cancer: Overall, our data demonstrate PDLIM2 epigenetic repression and RelA/STAT3 regulation of MHC-I, MDR1 and cancer-related genes as a previously unknown mechanism underlying lung cancer development and resistance to PD-1 blockade and chemotherapy.